Sandbox Reserved 1061: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 7: Line 7:
== Background ==
== Background ==


''Mycobacterium tuberculosis'' [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Wikipedia]resides in the lungs of a host and upon becoming active, results in symptoms such as chest pains, weakness, and intense coughing. Left untreated and unmanaged, TB can lead to death (1.5 million in 2013).<ref>"Tuberculosis." Media Centre. World Health Organization, Web. 16 Mar. 2015. Media Centre. <http://www.who.int/mediacentre/factsheets/fs104/en/>.</ref>The disease has a high co-morbidity with HIV/AIDS due to its immunocompromising tendencies. Tuberculosis is one of the most heavily studied diseases today. With over 9 million infections worldwide per year, the necessity for antimicrobial agents to combat emerging multi-drug resistant strands is imperative. <ref>"Tuberculosis." Media Centre. World Health Organization, Web. 16 Mar. 2015. Media Centre. <http://www.who.int/mediacentre/factsheets/fs104/en/>.</ref>
[http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Wikipedia ''Mycobacterium tuberculosis'']resides in the lungs of a host and upon becoming active, results in symptoms such as chest pains, weakness, and intense coughing. Left untreated and unmanaged, TB can lead to death (1.5 million in 2013).<ref>"Tuberculosis." Media Centre. World Health Organization, Web. 16 Mar. 2015. Media Centre. <http://www.who.int/mediacentre/factsheets/fs104/en/>.</ref>The disease has a high co-morbidity with HIV/AIDS due to its immunocompromising tendencies. Tuberculosis is one of the most heavily studied diseases today. With over 9 million infections worldwide per year, the necessity for antimicrobial agents to combat emerging multi-drug resistant strands is imperative. <ref>"Tuberculosis." Media Centre. World Health Organization, Web. 16 Mar. 2015. Media Centre. <http://www.who.int/mediacentre/factsheets/fs104/en/>.</ref>